CHRNA7 and Parkinson disease: α7-nAChRs are implicated in several neurological disorders such as schizophrenia, spectrum disorders, and both Alzheimer’s and Parkinson’s disease [3,4,5], and are considered appropriate targets for drug therapy [22].